Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I
Cardiovascular diseases (CVDs) are one of the foremost causes of mortality in intensive care units worldwide. The development of a rapid method to quantify cardiac troponin I (cTnI)—the goldstandard biomarker of myocardial infarction (MI) (or “heart attack”)—becomes crucial in the early diagnosis an...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | article |
| Published: |
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11073/21580 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|